DescriptionSources: http://www.accessdata.fda.gov/spl/data/34edbae8-e952-4908-a425-b9f029bb4502/34edbae8-e952-4908-a425-b9f029bb4502.xmlCurator's Comment: Description was created based on several sources, including https://www.drugs.com/monograph/senna.html and http://www.drugbank.ca/drugs/DB11365
Sources: http://www.accessdata.fda.gov/spl/data/34edbae8-e952-4908-a425-b9f029bb4502/34edbae8-e952-4908-a425-b9f029bb4502.xml
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/monograph/senna.html and http://www.drugbank.ca/drugs/DB11365
Sennosides are hydroxyanthracene glycosides derived from Senna leaves. They have been used as natural, safe time-tested laxatives in traditional as well as modern systems of medicine. Sennosides (Senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Senna is an FDA-approved nonprescription drug for adults and children ages 2 years and older. It is also used for bowel preparation before colonoscopy and diagnostic imaging.
Originator
Sources: https://www.drugs.com/npp/senna.html
Curator's Comment: Senna was first used medicinally by Arabian physicians in the 9th century A.D.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095173 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11218732 |
680.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | SENNA Approved UseRelieves occasional constipation (irregularity) Launch Date2012 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [The effects of kampo-formulation and the constituting crude drugs, prescribed for the treatment of peptic ulcer on H,K-ATPase activity]. | 2001-02 |
|
| [Effects of sennosides on cellular electric activities in smooth muscle cells of guinea pig taenia coli]. | 1993-09 |
|
| Effects of senna and its active compounds rhein and rhein-anthrone on PAF formation by rat colon. | 1992-08 |
Patents
Sample Use Guides
Adults and children 12 years of age or older - 2 tablets once a day starting dose; 4 tablets twice a day maximal dose; children 6 to under 12 years - 1 tablet once a day starting dose; 2 tablets twice a day maximal dose; each Senna Tablet contains: Sennosides 8.6 mg / Standardized Senna Concentrate
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8010034
Sennosides (20 mmol/l) induced spontaneous spike potentials in guinea pig taenia coli.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
A06AB06
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
||
|
DSLD |
1162 (Number of products:8)
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
||
|
WHO-ATC |
A06AB56
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
||
|
NCI_THESAURUS |
C29697
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3FYP5M0IJX
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
3FYP5M0IJX
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
DB11365
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
1612007
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108559
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
36387
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
C29448
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
SUB40994
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY | |||
|
4307
Created by
admin on Mon Mar 31 18:24:21 GMT 2025 , Edited by admin on Mon Mar 31 18:24:21 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD